Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHICL Infrastructure Regulatory News (HICL)

Share Price Information for HICL Infrastructure (HICL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 123.80
Bid: 123.60
Ask: 124.20
Change: 0.40 (0.32%)
Spread: 0.60 (0.485%)
Open: 123.20
High: 123.80
Low: 123.20
Prev. Close: 123.40
HICL Live PriceLast checked at -
HICL Infrastructure is an Investment Trust

To deliver a long-term, stable income to shareholders from a diversified portfolio of infrastructure investments positioned at the lower end of the risk spectrum.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Preliminary Results of Placing

21 Mar 2013 12:00

RNS Number : 5442A
HICL Infrastructure Company Ld
21 March 2013
 



HICL Infrastructure Company Limited

21 March 2013

Not for publication, release of distribution in whole or in part in Australia, Canada, South Africa, Japan or the United States

 

Preliminary Results of Placing, Open Offer and Offer for Subscription of New Ordinary Shares

The Board of HICL Infrastructure Company Limited ("HICL") is pleased to announce that the Placing, Open Offer and Offer for Subscription of New Ordinary Shares (the 'Issue') has now closed and that, on the basis of applications received through the Open Offer and Offer for Subscription and of orders taken through the Placing, both the Issue's target size of 100 million Ordinary Shares (raising gross proceeds of £119.5 million) and its maximum potential size of 140 million Ordinary Shares (raising gross proceeds of £167.3 million) have been comfortably exceeded.

In accordance with the terms and conditions of the Issue, all applications made pursuant to Open Offer entitlements will be met in full. The Board is, in conjunction with its advisers, considering the basis upon which applications made pursuant to the Placing, the Offer for Subscription and (to the extent it is relevant) the Excess Application Facility should be scaled back given the high level of oversubscription in respect of the Issue.

The Board has consulted with the Investment Adviser, InfraRed Capital Partners Limited, on the Additional Investments which would allow the size of the Issue to be increased. As a result, the Board has decided that the overall size of the Issue will be set at its maximum of 140 million New Ordinary Shares.

A further announcement providing details of the basis upon which New Ordinary Shares will be allotted will be made on Friday 22 March 2013.

For further information, please contact: 

InfraRed Capital Partners Limited

Tony Roper

Keith Pickard

Robin Hubbard

David Foot

Erwan Fournis

 

+44 (0) 20 7484 1800

Canaccord Genuity Limited

David Yovichic

Lucy Lewis

Robbie Robertson

 

+44 (0) 20 7523 8000

Tulchan Communications

Ed Orlebar

 

+44 (0) 20 7353 4200

Dexion Capital (Guernsey) Limited

Gillian Newton

+44 (0) 1481 732814

Terms in this announcement shall have the same meaning as defined in the prospectus issued by HICL dated 26 February 2013.

Canaccord Genuity Limited, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting for the Company and for no one else in connection with the Issue and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Canaccord Genuity Limited or for affording advice in relation to the Issue, or any other matters referred to herein.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCJBMLTMBTTMJJ
Date   Source Headline
11th Jun 20185:30 pmRNSAnnual Financial Report
11th Jun 20187:00 amRNSIncremental Acquisition
1st Jun 201811:01 amRNSScrip Dividend Alternative - Suspension
30th May 20188:31 amRNSDirector/PDMR Shareholding
29th May 20184:00 pmRNSDirector/PDMR Shareholding
25th May 201810:00 amRNSEU GDPR Data Privacy Notices
23rd May 20187:00 amRNSAnnual Financial Report
16th May 20182:00 pmRNSFourth Quarterly Interim Dividend
30th Apr 20187:00 amRNSDisposal of an investment
27th Apr 20187:00 amRNSNew Investments
17th Apr 20183:13 pmRNSDirector Declaration
17th Apr 201810:02 amRNSDirectorate Change
16th Apr 20187:25 amRNSNotice of Annual Results
16th Apr 20187:25 amRNSNew Investment
5th Apr 20183:00 pmRNSDirector/PDMR Shareholding
29th Mar 201812:00 pmRNSTotal Voting Rights
26th Mar 20185:00 pmRNSDirector/PDMR Shareholding
26th Mar 20185:00 pmRNSDirector/PDMR Shareholding
26th Mar 20185:00 pmRNSDirector/PDMR Shareholding
26th Mar 201812:00 pmRNSAdditional Listing
26th Mar 20187:00 amRNSIncremental Investment
21st Mar 20185:02 pmRNSDirector/PDMR Shareholding
19th Mar 20182:43 pmRNSDirector Declaration
8th Mar 20185:30 pmRNSScrip Share Reference Price
2nd Mar 20182:00 pmRNSDirector/PDMR Shareholding
21st Feb 201812:52 pmRNSThird Quarterly Interim Dividend
7th Feb 201811:36 amRNSCapital Markets Seminar
5th Feb 20187:00 amRNSInterim Update Statement
1st Feb 20187:00 amRNSRenewal of the Group's Revolving Credit Facility
30th Jan 20188:00 amRNSDirector/PDMR Shareholding
29th Jan 20185:05 pmRNSDirector/PDMR Shareholding
29th Jan 20182:20 pmRNSDirector/PDMR Shareholding
29th Jan 20182:19 pmRNSDirector/PDMR Shareholding
26th Jan 20185:12 pmRNSDirector/PDMR Shareholding
26th Jan 20185:10 pmRNSDirector/PDMR Shareholding
26th Jan 20183:54 pmRNSDirector/PDMR Shareholding
26th Jan 20183:53 pmRNSDirector/PDMR Shareholding
26th Jan 20187:00 amRNSUpdate on Service Provision
15th Jan 20188:55 amRNSService Provision Continuity
3rd Jan 20183:00 pmRNSDirector/PDMR Shareholding
29th Dec 20171:30 pmRNSTotal Voting Rights
22nd Dec 201710:22 amRNSAdditional Listing
21st Dec 20175:00 pmRNSPublication of Interim Report
20th Dec 201711:00 amRNSKey Information Document
30th Nov 20173:00 pmRNSScrip Share Reference Price
27th Nov 20177:00 amRNSDirector/PDMR Shareholding
22nd Nov 20177:00 amRNSInterim Results Six Months Ended 30 September 2017
16th Nov 20177:00 amRNSSecond Quarterly Interim Dividend
4th Oct 20177:00 amRNSDirector/PDMR Shareholding 30 September 2017
29th Sep 20173:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.